Six months in, three failed inserts deep, and the first step out of bed still feels like a nail through the heel. Here's how LAOSS podiatrists decide between extracorporeal shockwave therapy, a cortisone injection, and (rarely) plantar fascia release surgery — and which patient archetype each one actually fits.
Shockwave heals. Cortisone calms. Surgery releases.
If you're reading this, you've probably already done the front-line stretches, swapped inserts twice, iced a frozen water bottle every night, and watched the morning-step pain refuse to go away. About 90% of plantar fasciitis cases resolve with structured conservative care in 6–12 months. You are in the other 10% — the chronic, refractory group where the underlying plantar fascia has shifted from an inflammation problem to a degeneration problem (technically fasciosis, not fasciitis).
That shift matters because it changes which treatments make sense. At LAOSS we have three escalating tools for this group, and they do completely different things to the tissue:
Cortisone injection suppresses the inflammatory and pain signal — fast relief, insurance-covered, but it doesn't fix the underlying tissue and overusing it actively damages the fascia and heel fat pad.
Extracorporeal shockwave therapy (ESWT) delivers focused or radial acoustic pulses into the degenerated fascia to trigger a controlled micro-injury and neovascularization — slow build, self-pay, but it's aimed at actual tissue remodeling and the benefit can last.
Plantar fascia release surgery (endoscopic or open) cuts a portion of the fascia to relieve mechanical tension — last-line, recovery is real (6–12 weeks), reserved for patients who have failed everything else.
The right answer for most patients past 6 months isn't "pick one." It's a deliberate sequence — and the wrong sequence (repeated cortisone, no shockwave, then surgery) is how patients end up with a ruptured fascia and a worse foot than they started with.
Both regenerative shockwave and PRP target the underlying tissue rather than just suppressing pain. This short video walks through what to expect when conservative care has plateaued.
Animations licensed from ViewMedica · Swarm Interactive
The plantar fascia is a thick band of connective tissue that runs from the medial calcaneal tubercle (the inside-front edge of the heel bone) along the arch to the base of the toes. In a chronic case, ultrasound shows a thickened (typically >4 mm), disorganized fascia with degenerated collagen near the heel attachment — this is *fasciosis*, not *fasciitis*. That's why the late-stage conversation shifts from anti-inflammatory tools (cortisone, NSAIDs) to tissue-remodeling tools (shockwave, PRP) or mechanical decompression (surgical release).
There's no universal answer — but the decision usually breaks down along four axes: how long you've had it, what you've already tried, what your insurance reality is, and what your activity goals are.
Duration and prior treatment. Past 6 months with structured conservative care already done — physical therapy, night splints, off-the-shelf and custom orthotics, NSAIDs, activity modification — you're a candidate for an interventional escalation. Past 12 months with shockwave and cortisone already failed — you're a candidate for a surgical conversation.
Pain trajectory right now. Severe, acute pain spike with measurable function loss this week often warrants a single cortisone injection to break the cycle, even if your long-term plan is shockwave. Calming the pain enough to walk, work, and tolerate PT is a legitimate goal — the trap is treating cortisone as the durable answer and stacking shots until something tears.
Insurance and cost reality. Cortisone is a $30–$100 copay. ESWT is a self-pay procedure — expect roughly $200–$400 per session, with a typical course of 3 sessions over 3 weeks (so ~$1,000 for the series). Some plans cover ESWT in specific circumstances; we check yours and quote the exact number before you commit. Surgery is covered when medically indicated.
What you're trying to protect. If you're a runner, a postal worker, a nurse, or anyone who can't accept a small but real risk of plantar fascia rupture or heel fat pad atrophy from repeated steroid exposure — your conversation skips a second cortisone shot and goes straight to shockwave or PRP.
Most chronic plantar fasciitis is resolved without ever opening the skin. Surgery is the last 5–10% of patients, after a real attempt at the rest. Here's how we sequence both sides.
What most patients actually need past the 6-month mark — when conservative care has plateaued but surgery isn't yet appropriate.
Plantar fascia release surgery is reserved for refractory cases — most LAOSS podiatrists do this rarely because most cases resolve before surgery is appropriate.
Cost is often the deciding factor between shockwave and cortisone — and unlike a lot of clinics, we quote the number before you commit.
Cortisone injection for plantar fasciitis is a covered orthopedic service under virtually every commercial plan and Medicare. Your cost is typically just the specialist copay and a small injection fee.
Most commercial plans classify ESWT as investigational for plantar fasciitis, though some cover it after documented failure of conservative care. We check your coverage and quote the exact number before you commit.
Onset and durability are where these tools diverge the most. Knowing the curve helps you plan around real life.
The local anesthetic gives you a few hours of immediate relief. The steroid effect builds over 24–48 hours and runs its course over weeks.
ESWT works on tissue biology, not pharmacology. The timeline is measured in weeks of remodeling, not hours of pain relief.
We won't oversell shockwave, and we won't dismiss cortisone — and we won't rush you to surgery you don't need.
Multiple randomized trials and meta-analyses support ESWT for chronic plantar fasciitis. The benefit profile is best in the patients this page is written for: 6+ months of symptoms, failed conservative care.
Decades of trials support cortisone for short-term pain relief in plantar fasciitis. The catch is durability and the well-documented harm of repeated injection.
These checklists are a starting point — the final call comes at your evaluation, with ultrasound imaging and exam findings in front of us.
ESWT is the strongest non-surgical move for the chronic, conservative-care-failed group — and the right call when tissue remodeling matters more than fast symptom suppression.
A single cortisone injection has a real, evidence-supported role — as a circuit-breaker for an acute pain spike that's blocking function and rehab.
Surgery is the last 5–10% of chronic plantar fasciitis cases — but for the patients who genuinely need it, it can be the right call.
Plantar fascia release is appropriate for a specific patient — refractory, well-documented, and not in a rush.
When surgery is the right call, the technique conversation comes next. Endoscopic release fits most candidates; open release is reserved for select cases.
Recovery timelines diverge sharply across these three options — cortisone is measured in days, shockwave in weeks, surgery in months.
Cortisone is an in-and-out office procedure. Most patients walk out and resume normal activity the same day.
ESWT triggers a controlled healing response. You'll feel sore for a day or two after each session — that's the response working.
Endoscopic plantar fascia release is a real operation. The recovery is months, not weeks — but for the right patient, the result can be durable.
For the patient this page was written for — chronic plantar fasciitis past 6 months, failed conservative care — there's a sequence we run more often than any other.
Step one is to confirm the diagnosis on ultrasound. A non-trivial number of "chronic plantar fasciitis" cases turn out to be heel fat pad atrophy, calcaneal stress reaction, tarsal tunnel syndrome, or Baxter's nerve entrapment — all of which look similar from the outside and respond to completely different treatments. We image at the evaluation visit.
Step two, if the diagnosis confirms, is usually a single ultrasound-guided cortisone injection — if you've never had one or it's been over a year, and if a pain reset would meaningfully help you tolerate PT and the shockwave course. This is not a long-term answer. It's a circuit-breaker.
Step three is a full shockwave course — 3 sessions over 3 weeks — paired with continued PT, eccentric calf work, and a night splint. We re-evaluate at week 8 and again at week 12.
Step four, if shockwave and cortisone both fail at 12+ months, is a surgical conversation about endoscopic plantar fascia release. Most LAOSS podiatrists do this rarely — not because we're philosophically opposed, but because most cases genuinely resolve before this point with the steps above. The patients who actually need surgery are a small minority, and they're better off for the deliberate work-up that got them there.
There are also situations where the answer is none of these yet — if your PT was unstructured, if the orthotic was off-the-shelf when a custom would have helped, if you stopped the night splint at three weeks, we'll tell you that too and rebuild the conservative plan before escalating.
All three options are well-tolerated when delivered by experienced specialists — but the risk profiles are very different.
A single cortisone injection is low-risk. The danger is in the third and fourth shot of the year, not the first one.
ESWT is one of the lowest-risk interventions in podiatry. The main considerations are cost, response variability, and a few absolute contraindications.
Chronic plantar fasciitis at LAOSS is managed by board-certified podiatrists with deep experience in heel pain — diagnostic ultrasound, image-guided injection, shockwave therapy, and (when truly needed) surgical release. The same podiatrist who confirms the diagnosis on ultrasound is the one performing the injection or the shockwave course. No hand-offs, no marketing-driven "plantar fasciitis packages," no rushing you toward the most expensive option in the room.
Dr. Acosta saved me from spine surgery. I came in convinced I was going to need an operation. He laid out a non-surgical plan that's been working. So thankful.
Book a visit at any of our eight Los Angeles-area offices. A board-certified podiatrist will examine the heel, image it on-site, and tell you straight whether shockwave, cortisone, surgery, or a sequence of the above is the right next step.
